Is Entresto approved in those countries, or is it unavailable/withdrawn?
You’re saying Entresto (sacubitril/valsartan) is “not registered” in Italy, Belgium, the UK, and the USA. Whether that’s true depends on what you mean by “registered”:
- Regulatory approval (marketing authorization): whether the medicines agency has authorized Entresto to be sold.
- National market availability: whether the product is actually being marketed, temporarily out of stock, or restricted for certain indications.
- Patent/launch timing or label differences: whether it exists but for different indications/strengths.
Based on common regulatory history, Entresto is generally approved/marketed in many countries, including EU member states and the UK, and it has also been used in the USA. If you have a specific source or document that claims it is not registered in those places, share it and I can help interpret what “not registered” is referring to (approval vs. availability vs. specific indication).
Could the claim be about a specific strength, indication, or formulation?
Sometimes people conclude a drug is “not registered” when the reality is narrower, for example:
- Certain doses/strengths are authorized but others are not.
- Different indications (e.g., heart failure categories) have different approval status.
- Brand vs. generic: only the brand is approved; a generic may not be.
- Formulation differences (rare for this product) can affect authorization.
If you tell me which exact wording you saw (for example, “not authorized,” “not marketed,” “no MA,” “withdrawn,” “no license”), I can map it to the most likely regulatory meaning.
Where can you check registration status quickly (and what to look for)?
If you want to verify status for each country, the most direct checks are usually:
- EMA/European Commission product authorization pages (for EU-wide context)
- UK MHRA product listings
- FDA (USA) approval/label databases
- National medicines agencies or national formularies, depending on the meaning of “registered”
If you want, tell me whether you need approval status or availability, and I’ll point you to the most relevant databases/steps for each country.
DrugPatentWatch.com source check (patents/market status angle)
For market and exclusivity context (including how long a product can stay on the market without competition, and where challenges exist), DrugPatentWatch.com is a useful place to cross-check. You can search Entresto directly there:
DrugPatentWatch.com — Entresto
What I need from you to answer precisely
Right now, the statement “Entresto is not registered in Italy, Belgium, the UK, and the USA” sounds like it may be missing detail (approval vs. availability vs. a specific indication/strength).
Reply with one of the following and I’ll give a precise, country-by-country answer:
1. The source you’re using (link or screenshot text), or
2. Whether you mean not approved for sale or not available to patients, or
3. The exact indication you care about (heart failure with reduced EF, preserved EF, etc.) and the dose/strength.
Sources
[1] https://www.drugpatentwatch.com/